CPHI North America 2023 | Philadelphia, PA
25 April 2023 - 27 April 2023Join Quotient Sciences at CPHI North America 2023 in Philadelphia from April 25-27. We will be holding meetings to discuss Quotient Sciences expanded global formulation and manufacturing service offerings.
Join us for our evening seminar
"How to Accelerate Drug Product Optimization Using Translational Pharmaceutics®"
Tuesday, October 25. Registration beginning at 5:30 PM
Join us during CPHI in Barcelona for our evening seminar at Hotel SB Plaza Europa on October 25. John McDermott, VP of Scientific Consulting and Dr.Andrew Parker, Senior Drug Development Consultant evaluate the existing reformulation paradigm when compared with Translational Pharmaceutics®, and share insight gained from 15 years of experience in accelerating the drug product optimization using real-world case studies.
Advanced registration is required and spaces are limited!
Dr. Paul Quigley, Principal Research Fellow for Drug Substance, and Brad Rowe, Senior Director of Integrated Development, will be participating in our partner meetings.
Also attending will be:
- Jamie Wiesharr - Head of Business Development
- Tobi Williams - Senior Director of Business Development
- Nabil Lally - Senior Director, Business Development
If you are planning on attending and would like to discuss your drug development and manufacturing needs with our experts, schedule a meeting today using the form below.
About our experts who are attending CPHI North America 2023
Dr. Paul Quigley, Principal Research Fellow, Drug Substance
Dr. Paul Quigley was head of Technology Transfer for Johnson Matthey Ltd. and previously head of New Product Introduction and Head of Technical Services for Shasun. Paul has over 20 years experience in the fine chemical and pharmaceutical industries in a variety of senior management roles, covering technical management of UK sites and senior project and operational roles within a number of international organizations including ICI, Schering Plough, Clariant, Johnson Matthey and Rhodia. Paul received his Ph.D. in Natural Product Chemistry from University College Dublin and MBA from Warwick Business School. He has co-authored a number of papers in the areas of biocatalysis, organic synthesis, polymer chemistry and natural product chemistry, and has generated several patents in this area. Paul is a Member of the Royal Society of Chemistry and the Association of MBAs.
Brad Rowe, Senior Director of Integrated Development
Brad Rowe has over 18 years of pharmaceutical product laboratory and testing support experience, as well as project management and general program guidance responsibilities. He has a background in analytical chemistry and has overseen teams in a variety of testing support including analytical method development and validation, product testing and QC ranging from pre-clinical through commercial marketed products.